|
FY2023
12 months to Jan 31, 2023
|
FY2022
12 months to Jan 31, 2022
|
FY2021
12 months to Jan 31, 2021
|
|
|---|---|---|---|
| Revenue | |||
| Cost of revenue | |||
| Gross profit | |||
| Operating expenses: | |||
| Research and development | |||
| Sales and marketing | |||
| General and administrative | |||
| Impairment of capitalized internal-use software | |||
| Total operating expenses | |||
| Loss from operations | |||
| Interest and other income (expense), net | |||
| Interest expense | |||
| Loss before provision for income taxes | |||
| Provision (benefit) for income taxes | |||
| Net loss | |||
| Net loss per share, basic and diluted (in USD per share) | |||
| Weighted-average number of shares outstanding, basic and diluted (in shares) | |||
| Net loss per share, diluted (in USD per share) | |||
| Net loss per share, basic (in USD per share) | |||
| Weighted-average number of shares outstanding, diluted (in shares) | |||
| Weighted-average number of shares outstanding, basic (in shares) |
Loading...
